Topic Hub
7 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 7 of 7 clinical reviews.
A clinical breakdown of spironolactone's FDA approval history, current label indications, compounding legality under federal 503A and 503B frameworks, and the evidence base for off-label acne prescribing.
Read clinical reviewA clinical review of spironolactone adverse event reports in the FDA's FAERS database, covering hyperkalemia, hormonal effects, the black box warning, and monitoring guidance for off-label acne use.
Read clinical reviewHow the FDA and European regulators differ on spironolactone for acne, why neither has granted a formal indication, and what the evidence says about off-label prescribing.
Read clinical reviewA comprehensive review of spironolactone's regulatory status worldwide, including FDA approval history, off-label dermatologic use, EMA classification, and post-market safety surveillance data.
Read clinical reviewA clinical review of FDA label changes to spironolactone between 2020 and 2026, with specific focus on off-label acne use, safety warnings, and post-market surveillance findings.
Read clinical reviewSpironolactone has been used off-label for hormonal acne for decades, yet no FDA-approved acne indication exists. Explore the legal, patent, and regulatory barriers that keep this drug in off-label territory.
Read clinical reviewA clinical review of spironolactone's regulatory history, current off-label acne use, emerging topical formulations, and next-generation antiandrogens in development for hormonal acne.
Read clinical review